Paper39666166
Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS).
Oliveira M and 7 others. Drug Saf, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS). Papers, record 39666166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39666166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS).
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adverse Drug Reaction Reporting Systems | Major topic |
| Product Surveillance, Postmarketing | Major topic |
| Pneumococcal Vaccines | Major topic |
| Drug-Related Side Effects and Adverse Reactions | Major topic |
| Humans | |
| United States | |
| Adult | |
| Middle Aged | |
| Aged | |
| Male | |
| Female | |
| Young Adult | |
| United States Food and Drug Administration | |
| Guillain-Barre Syndrome | |
| Vaccines, Conjugate | |
| Aged, 80 and over |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CC999999 | Intramural CDC HHS | United States | PubMed |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20600491 | Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. | Vaccine | 2011 | https://conductscience.org/library/papers/20600491 | PubMed |
| 2 | 29977960 | Pneumococcal Conjugate Vaccine Safety in Elderly Adults. | Open Forum Infect Dis | 2018 | https://conductscience.org/library/papers/29977960 | PubMed |
| 3 | 34315611 | A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age. | Vaccine | 2021 | https://conductscience.org/library/papers/34315611 | PubMed |
| 4 | 25108215 | The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. | Vaccine | 2014 | https://conductscience.org/library/papers/25108215 | PubMed |
| 5 | 21422765 | Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. | Neuroepidemiology | 2011 | https://conductscience.org/library/papers/21422765 | PubMed |
| 6 | 35085226 | Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. | MMWR Morb Mortal Wkly Rep | 2022 | https://conductscience.org/library/papers/35085226 | PubMed |
| 7 | 34088506 | U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines. | Vaccine | 2021 | https://conductscience.org/library/papers/34088506 | PubMed |
| 8 | 26312010 | International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. | J Pharmacol Pharmacother | 2015 | https://conductscience.org/library/papers/26312010 | PubMed |
| 9 | 12071774 | Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. | Drug Saf | 2002 | https://conductscience.org/library/papers/12071774 | PubMed |
| 10 | 32716500 | Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32716500 | PubMed |
| 11 | 26209838 | Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). | Vaccine | 2015 | https://conductscience.org/library/papers/26209838 | PubMed |
| 12 | 34940806 | Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years. | Clin Infect Dis | 2022 | https://conductscience.org/library/papers/34940806 | PubMed |
| 13 | 23580737 | Lack of association of Guillain-Barré syndrome with vaccinations. | Clin Infect Dis | 2013 | https://conductscience.org/library/papers/23580737 | PubMed |
| 14 | 36435707 | Anaphylaxis: Revision of the Brighton collaboration case definition. | Vaccine | 2023 | https://conductscience.org/library/papers/36435707 | PubMed |
| 15 | 14741144 | Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. | Vaccine | 2004 | https://conductscience.org/library/papers/14741144 | PubMed |
| 16 | 27836437 | Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012-December 31, 2015. | Vaccine | 2016 | https://conductscience.org/library/papers/27836437 | PubMed |
| 17 | 36265846 | Safety Surveillance of Varicella Vaccines in the Vaccine Adverse Event Reporting System, United States, 2006-2020. | J Infect Dis | 2022 | https://conductscience.org/library/papers/36265846 | PubMed |
| 18 | 19880172 | Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. | Lancet | 2009 | https://conductscience.org/library/papers/19880172 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42576235 | Real-world analysis of depression-related adverse events associated with the adsorbed anthrax vaccine: integrating pharmacovigilance signals, machine learning risk prediction, and transcriptomic mechanisms. | Infect Dis Poverty | 2026 | https://conductscience.org/library/papers/42576235 | PubMed |
| 42289946 | A Comprehensive Disproportionality Analysis of Drug-Related Head Injury Reports Using the FAERS Database. | Brain Behav | 2026 | https://conductscience.org/library/papers/42289946 | PubMed |
| 42198362 | Disproportionality Analysis and Timing of Drug-Associated Guillain-Barré Syndrome Onset Based on the Japanese Adverse Drug Event Report Database. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42198362 | PubMed |
| 40934012 | Post-marketing safety surveillance of pneumococcal vaccines: a real-world pharmacovigilance study using the U.S. vaccine adverse event reporting system (VAERS) database. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40934012 | PubMed |
| 40678810 | Post-licensure safety of respiratory syncytial virus vaccines, Vaccine Adverse Event Reporting System, United States, May 2023-December 2024. | Prev Med Rep | 2025 | https://conductscience.org/library/papers/40678810 | PubMed |
| 40557316 | Real-world pharmacovigilance reports of hepatitis A inactivated and hepatitis B (recombinant) vaccine: insights from disproportionality analysis of the vaccine adverse event reporting system. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40557316 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39666166
GET https://conductscience.org/api/papers/v1/39666166/authors